A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication

被引:49
作者
Iro, Michaela [1 ]
Witteveldt, Jeroen [1 ]
Angus, Allan G. N. [1 ]
Woerz, Ilka [2 ]
Kaul, Artur [2 ]
Bartenschlager, Ralf [2 ]
Patel, Arvind H. [1 ]
机构
[1] Univ Glasgow, Inst Virol, MRC Virol Unit, Glasgow G11 5JR, Lanark, Scotland
[2] Univ Heidelberg, Dept Mol Virol, D-69120 Heidelberg, Germany
基金
英国医学研究理事会;
关键词
Hepatitis C virus; HCV; Chimera; Reporter cell line; SEAP; NS3/4A protease; IN-VITRO; E2; GLYCOPROTEIN; CULTURE; PROTEASE; RNA; VIABILITY; PARTICLES; CHIMERAS; CLEAVAGE; VX-950;
D O I
10.1016/j.antiviral.2009.04.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human pathogen hepatitis C virus (HCV) is associated with chronic liver disease. The recent development of the cell culture infectious HCV (HCVcc) system has opened up avenues for detailed studies on the life cycle of the virus and its interaction with the host cell. Current methods to quantitate virus infectivity in cell culture are time-consuming and labor-intensive. This study describes the generation of a cell-based secreted alkaline phosphatase (SEAP) reporter assay to facilitate in vitro studies of HCV infection and replication. This assay is based on a novel reporter cell line stably expressing the enhanced green fluorescent protein (EGFP) fused in-frame to the secreted alkaline phosphatase via a recognition sequence of the viral NS3/4A serine protease. The SEAP reporter from a similar construct has previously been shown to be released from the fusion protein and be secreted into the extracellular culture medium following cleavage by the viral NS3/4A protease. The reporter cell line enabled rapid and sensitive quantification of HCV infection and viral replication in cell culture. The utility of this system for investigating virus entry, and for high throughput screening of entry inhibitors and other antiviral compounds was demonstrated using several inter- and intra-genotypic chimeras of HCV. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:148 / 155
页数:8
相关论文
共 37 条
[1]   Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].
Bartosch, B ;
Dubuisson, J ;
Cosset, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642
[2]   Epidemiological changes in hepatitis C virus genotypes in France:: evidence in intravenous drug users [J].
Bourlière, M ;
Barberin, JM ;
Rotily, M ;
Guagliardo, V ;
Portal, I ;
Lecomte, L ;
Benali, S ;
Boustière, C ;
Perrier, H ;
Jullien, M ;
Lambot, G ;
Loyer, R ;
LeBars, O ;
Daniel, R ;
Khiri, H ;
Halfon, P .
JOURNAL OF VIRAL HEPATITIS, 2002, 9 (01) :62-70
[3]   Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs [J].
Carroll, SS ;
Tomassini, JE ;
Bosserman, M ;
Getty, K ;
Stahlhut, MW ;
Eldrup, AB ;
Bhat, B ;
Hall, D ;
Simcoe, AL ;
LaFemina, R ;
Rutkowski, CA ;
Wolanski, B ;
Yang, ZC ;
Migliaccio, G ;
De Francesco, R ;
Kuo, LC ;
MacCoss, M ;
Olsen, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (14) :11979-11984
[4]   The use of hepatitis C virus NS3/4A and secreted alkaline phosphatase to quantitate cell-cell membrane fusion mediated by severe acute respiratory syndrome coronavirus S protein and the receptor angiotensin-converting enzyme 2 [J].
Chou, Chih-Fong ;
Shen, Shuo ;
Mahadevappa, Geetha ;
Lim, Seng Gee ;
Hong, Wanjin ;
Tan, Yee-Joo .
ANALYTICAL BIOCHEMISTRY, 2007, 366 (02) :190-196
[5]   Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles [J].
Clayton, RF ;
Owsianka, A ;
Aitken, J ;
Graham, S ;
Bhella, D ;
Patel, AH .
JOURNAL OF VIROLOGY, 2002, 76 (15) :7672-7682
[6]   Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C [J].
Forestier, Nicole ;
Reesink, Hendrik W. ;
Weegink, Christine J. ;
McNair, Lindsay ;
Kieffer, Tara L. ;
Chu, Hui-May ;
Purdy, Susan ;
Jansen, Peter L. M. ;
Zeuzem, Stefan .
HEPATOLOGY, 2007, 46 (03) :640-648
[7]   Development and Characterization of Hepatitis C Virus Genotype 1-7 Cell Culture Systems: Role of CD81 and Scavenger Receptor Class B Type I and Effect of Antiviral Drugs [J].
Gottwein, Judith M. ;
Scheel, Troels K. H. ;
Jensen, Tanja B. ;
Lademann, Jacob B. ;
Prentoe, Jannick C. ;
Knudsen, Maria L. ;
Hoegh, Anne M. ;
Bukh, Jens .
HEPATOLOGY, 2009, 49 (02) :364-377
[8]   CHARACTERIZATION OF THE HEPATITIS-C VIRUS-ENCODED SERINE PROTEINASE - DETERMINATION OF PROTEINASE-DEPENDENT POLYPROTEIN CLEAVAGE SITES [J].
GRAKOUI, A ;
MCCOURT, DW ;
WYCHOWSKI, C ;
FEINSTONE, SM ;
RICE, CM .
JOURNAL OF VIROLOGY, 1993, 67 (05) :2832-2843
[9]   Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation [J].
Honda, M ;
Kaneko, S ;
Matsushita, E ;
Kobayashi, K ;
Abell, GA ;
Lemon, SM .
GASTROENTEROLOGY, 2000, 118 (01) :152-162
[10]   Course and outcome of hepatitis C [J].
Hoofnagle, JH .
HEPATOLOGY, 2002, 36 (05) :S21-S29